Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Sex-Dimorphic Hormonal Signaling in Sarcopenia (Apelin–Insulin–Oxytocin)

Current understanding

Narrative review evidence [expert-opinion] proposes that skeletal muscle aging follows partially non-overlapping hormonal trajectories in men and women, with apelin (myokine/adipokine), insulin (anabolic/nutrient-sensing), and oxytocin (regenerative signaling) each showing sex-dimorphic declines and downstream effects on satellite-cell function, protein balance, and neuromuscular junction integrity. The synthesis is [mechanism-plausible] at the level of individual hormone–muscle axes but has no primary comparative human trial data yet; the clinical pitch of sex-stratified sarcopenia therapy currently outruns interventional evidence.

Evidence log

Open questions

Related

Contributing findings

pubmed review
Hormonal dimorphism in sarcopenia disease.
26-jun-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18